We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

21 hedge funds and large institutions have $793K invested in Bio-Path Holdings Inc in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0% more funds holding

Funds holding: 21 → 21 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

17% less capital invested

Capital invested by funds: $955K → $793K (-$162K)

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$31.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$28.2K
3
Bank of America
Bank of America
North Carolina
+$5.58K
4
Group One Trading
Group One Trading
Illinois
+$3.6K
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.98K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$201K
2
UBS Group
UBS Group
Switzerland
-$4.64K
3
TRCT
Tower Research Capital (TRC)
New York
-$2.05K
4
MCC
Money Concepts Capital
Florida
-$453
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$332K +$31.3K +871 +8%
Walleye Capital
2
Walleye Capital
New York
$104K -$201K -5,589 -60%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$93.6K – – –
BlackRock
4
BlackRock
New York
$67.4K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$49.3K +$28.2K +784 +79%
MYIA
6
Mount Yale Investment Advisors
Colorado
$35.2K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$28K +$1.98K +55 +6%
Northern Trust
8
Northern Trust
Illinois
$24.6K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$19K – – –
State Street
10
State Street
Massachusetts
$18.1K – – –
TRCT
11
Tower Research Capital (TRC)
New York
$9K -$2.05K -57 -15%
Bank of America
12
Bank of America
North Carolina
$4.53K +$5.58K +155 +1,938%
Group One Trading
13
Group One Trading
Illinois
$2.78K +$3.6K +100 New
UBS Group
14
UBS Group
Switzerland
$2.62K -$4.64K -129 -58%
JP Morgan Chase
15
JP Morgan Chase
New York
$1K +$828 +23 New
Morgan Stanley
16
Morgan Stanley
New York
$973 – – –
CA
17
Crewe Advisors
Utah
$98 – – –
GRP
18
Global Retirement Partners
California
$98 – – –
Wells Fargo
19
Wells Fargo
California
$76 +$36 +1 +50%
Osaic Holdings
20
Osaic Holdings
Arizona
$14 – – –
MCC
21
Money Concepts Capital
Florida
– -$453 -15 Closed

BPTH Hedge Fund Activity: Q1 2023 in Review

21 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2023, worth a combined $793K — down 17% from $955K a quarter earlier.

Fund positioning in BPTH was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $31.3K. The largest seller was Walleye Capital, cutting an estimated $201K.

  • 21 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $793K of Bio-Path Holdings Inc stock for Q1 2023, down 17% quarter-over-quarter.
  • 2 funds opened new Bio-Path Holdings Inc positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest Bio-Path Holdings Inc buyer in Q1 2023 was Vanguard Group, an estimated $31.3K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2023 was Walleye Capital, an estimated $201K sold.

Based on aggregated 13F filings for Q1 2023.